Evidence map›Paper›PMID 22974808›Full record

ReviewJACC. Cardiovascular imaging2012

Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Jerome L Fleg, Gregg W Stone, Zahi A Fayad, Juan F Granada, Thomas S Hatsukami, Frank D Kolodgie, Jacques Ohayon, Roderic Pettigrew, Marc S Sabatine, Guillermo J Tearney and 4 more

Abstract readReview
In one paragraph

Review in JACC. Cardiovascular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 227 citations in OpenAlex.

  1. Vascular medicine (London, England) · 2025
    Pooled it
  2. Guideline
  3. Trial
  4. European journal of nuclear medicine and molecular imaging · 2020
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Lagrangian deformation tracking for strain imaging.Progress in biomedical engineering (Bristol, England) · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. UsingQuantitative imaging in medicine and surgery · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. The role of non-stenosing carotid artery plaques in embolic stroke of undetermined source, is it a silent offender? A review of literature.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Jerome L FlegDivision of Cardiovascular Sciences, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA. flegj@nhlbi.nih.gov
Gregg W Stone
Zahi A Fayad
Juan F Granada
Thomas S Hatsukami
Frank D Kolodgie
Jacques Ohayon
Roderic Pettigrew
Marc S Sabatine
Guillermo J Tearney
Sergio Waxman
Michael J Domanski
Pothur R Srinivas
Jagat Narula
Icahn School of Medicine at Mount Sinai · USColumbia University Irving Medical Center · USNational Heart Lung and Blood Institute · USNational Institute of Diabetes and Digestive and Kidney Diseases · USCardiovascular Institute Hospital · JPHarvard University · USHarvard University Press · USTufts University · USUniversity of Washington · US

Funding

Bioimaging and Biomechanics of Atheromatous PlaqueZIADK075082 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI PETTIGREW, RODERIC · 2013 to 2017
$2.8M
Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

The leading cause of major morbidity and mortality in most countries around the world is atherosclerotic cardiovascular disease, most commonly caused by thrombotic occlusion of a high-risk coronary plaque resulting in myocardial infarction or cardiac death, or embolization from a high-risk carotid plaque resulting in stroke. The lesions prone to result in such clinical events are termed vulnerable or high-risk plaques, and their identification may lead to the development of pharmacological and mechanical intervention strategies to prevent such events. Autopsy studies from patients dying of acute myocardial infarction or sudden death have shown that such events typically arise from specific types of atherosclerotic plaques, most commonly the thin-cap fibroatheroma. However, the search in human beings for vulnerable plaques before their becoming symptomatic has been elusive. Recently, the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study demonstrated that coronary plaques that are likely to cause future cardiac events, regardless of angiographic severity, are characterized by large plaque burden and small lumen area and/or are thin-cap fibroatheromas verified by radiofrequency intravascular ultrasound imaging. This study opened the door to identifying additional invasive and noninvasive imaging modalities that may improve detection of high-risk atherosclerotic lesions and patients. Beyond classic risk factors, novel biomarkers and genetic profiling may identify those patients in whom noninvasive imaging for vulnerable plaque screening, followed by invasive imaging for risk confirmation is warranted, and in whom future pharmacological and/or device-based focal or regional therapies may be applied to improve long-term prognosis.

Indexed as

Diagnostic ImagingAnimalsBiomarkersCarotid Artery DiseasesCoronary Artery DiseaseCoronary VesselsDisease Models, AnimalEmbolismGenetic TestingHumansMyocardial InfarctionPlaque, AtheroscleroticPredictive Value of TestsPrognosisRisk AssessmentRisk FactorsBiomarkers

Identifiers

PMID22974808
PMCPMC3646061
OpenAlexW1606839159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.